CoChat

Sibutramine: A Novel New Agent for Obesity Treatment

Open access
Ryan, Donna H., Kaiser, Pam, Bray, George A. · 1995 · Obesity Research
Cited by 102

The DOI matches its Crossref record.

Abstract

Sibutramine is a novel new pharmacologic agent which is a specific reuptake inhibitor for norepinephrine and serotonin. Preclinical data show that sibutramine and its two metabolites reduce food intake of animals eating either high or low carbohydrate diets and of obese Zucker rats. An 8‐week clinical trial showed a dose‐dependent decrease on body weight. Sibutramine, 5 and 20 mg/day, produced a dose‐related weight loss in obese subjects compared to placebo in an 8‐week trial. In doses varying from 1 to 30 mg, sibutramine also produced a dose‐dependent decrease in weight in the healthy obese population when used in 6‐,8‐,12–24‐ and 52‐week trials. Although the majority of the weight loss occurred during the first 12 weeks of treatment, weight loss had not plateaued in by 24 weeks in the higher doses. Side effects were mild. This drug shows promise as an antiobesity drug.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/j.1550-8528.1995.tb00227.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 102

Metadata

Authors
Ryan, D. H., Kaiser, P., & Bray, G. A.
Venue
Obesity Research
Publisher
Wiley
Published
1995-11
Volume
3
Issue
S4
Pages
553S-559S
ISSN
  • 1071-7323 (ISSN-L)
  • 1550-8528
OpenAlex
W1984562645
Cited by
102
References
0
FWCI
5.18
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sibutramine: A Novel New Agent for Obesity Treatment. https://app.cochat.ai/papers/10.1002/j.1550-8528.1995.tb00227.x
The paper
Ryan, D. H., Kaiser, P., & Bray, G. A. (1995). Sibutramine: A Novel New Agent for Obesity Treatment. Obesity Research. https://doi.org/10.1002/j.1550-8528.1995.tb00227.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.